QA: Uniqure N V in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001590560_2022_Uniqure_N_V.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0001590560, Uniqure N V

  xvar xval
0 AssetsCurrent 628,239,000
1 IntangibleAssetsNetIncludingGoodwill 90,319,000
2 PropertyPlantAndEquipmentNet 43,505,000
3 remainder_Assets 47,117,000
4 LiabilitiesCurrent 36,763,000
5 LiabilitiesNoncurrent 176,641,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 24,976,000
8 SellingGeneralAndAdministrativeExpense 59,766,075
9 ResearchAndDevelopmentExpense 148,221,484
10 remainder_Expenses -11,261,813
11 remainder_Revenues 3,009,296,006
12 remainder_NetIncome -12,010,393
13 remainder_ComprehensiveNetIncome 16,518,969
  yvar yval
0 Assets 809,180,000
1 Liabilities 213,404,000
2 Expenses 221,701,746
3 Revenues 3,009,296,006
4 StockholdersEquity 595,776,000
5 NetIncome 2,775,583,867
6 ComprehensiveNetIncome 2,783,843,352
7 BaseVar 2,141,055,557
8 EconomicCapitalRatiobeforeLimitedLiability 7.98
9 EconomicCapitalRatio 7.99

Edgar->Model Mapping

Feature Distribution

Change over Time